EuroHealth%reg;
EuroHealth®
 
   
EuroHealth%reg; EuroHealth%reg; EuroHealth%reg; EuroHealth%reg; EuroHealth%reg;
DHEA Références   [Imprimer]

Albrecht, E.D.; Henson, M.C., et al.: Modulation of adrenocorticotropin-stimulated baboon fetal adrenal dehydroepiandrosterone formation in vitro by estrogen at mid- and late gestation. Endocrinology 126(6), 1990 Jun; 3083-3088.

Araghi-Niknam, M., Liang, B., et al.: Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by Dehydroepiandrosterone sulphate (DHEAS). Immunology, 0(3):344-9, 1997.

Araneo BA; Ryu SY; Barton S; Daynes RA: Dehydroepiandrosterone reduces progressive dermal ischemia caused by thermal injury. J Surg Res 1995 Aug; 59(2): 250-62 Argtielles, A.E. et al., Endocrine profiles and breast cancer. Lancet, 1973; 1:165-168.

Arguelles, A. E., Poggi, U. L., Saborida, C., Hoffman, C., Chekherdemian, M., Blanchard, O.: Endocrine Profiles and Breast Cancer. Lancet, 1:165-168,1973.

Barrett-Connor, E., Khaw, K.T., Yen, S.S.: A prospective study of Dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med, 315:24, 1519-24, 1986, Dec 11.

Barrett-Conor, E.; Edelstein, S.L.: A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study. J. Am. Geriatr. Soc. 42(4), 1994 Apr.; 420-423.

Berkenhager-Gillesse, E.G., et al.: Dehydroepiandrosterone sulphate (DHEA-S) in the oldest, old, aged 85 and over. Ann N Y Acad Sci (719), May 31, 1994; 543-552.

Berr, C., Lafont, S., et al.: Relationship of Dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A, Vol. 93, pg 13410-13415, 1996 Nov 12.

Browne, E.S., et al.: Dehydroepiandrosterone: Antiglucoconicoid action in mice. Am J Med Sci, 1992; 303:366-371.

Calabrese, B.P.; Isaacs, E.R.; Regelson, W.: Dehydroepiandrosterone in multiple sclerosis: positive effects on fatigue syndrome in a non-randomizing study. In the biological role of dehydroepiandrosterone. Edited by M. Kalimi and W. Regelson, New York: de Gruyter, 1990; 95-100.

Casson P.R., Faquin, L.C., et al.: Replacement of Dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril,63(5):1027-31, 1995 May.

Casson, P.R., Andersen, R.N., et al.: Oral Dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Mosby, Year Book, 1993.

Cherniske, Stephen, M.S.: The DHEA Breakthrough. Ballantine Books.

Cleary, M.P.; Shepherd, P.; Jenits, B.: Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. J Nutr, 1984; 114:1242-1251.

Cohen, S., Tyrrell, D.A., Smith, A.P.: Psychological stress and susceptibility to the common cold. N Engl J Med, 325(9):606-12, 1991, Aug 29.

Coleman, D.L.; Laiter, E.H.; Applerweig, N.: Therapeutic effects of dehydroepiandrosterone metabolities in diabetes mutant mice. Endocrinology, 1984; 115, 239-243.

Danenberg, H.D., Ben-Yehuda, A., et al.: Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine, 13(15):1445-8, 1995.

Diamond, P., Cusan, L., Gomez, J.L., et al.: Metabolic effects of 12 mo. percutaneous Dehydro-epi-androsterone replacement therapy in postmenopausal women. J Endocr,150 Suppl(): S43-50, 1996 .

Drocker, W.D.; Blumberg, J.M., et al.: Biologic activity of dehydroepiandrosterone sulfate in man. Journal of Clinical Endocrinology, 1972; 35, 48-0.

Ebeling, P.; Koivisto, V.A.: Physiological importance of dehydroepiandrosterone. Eng J Clin Endocrinol Metab 78(6), 1994 Jun; 15-20.

Faasati, P.; Fassati, M., et al.: Treatment of stabilized liver cirrhosis by dehydroepiandrosterone. Agressologia 14(4), 1973; 259-268.

Gordon, G.; Bush, D.; Weisman, H.: Reduction of arteriosclerosis by administration of dehydroepiandrosterone. J Clin Invest., Department of Medicine, Johns Hopkins Medical Institutions, 1988 Aug; 82(2):712-720.

Haffa AL; MacEwen EG; Kurzman ID; Kemnitz JW.: Hypocholesterolemic effect of exogenous dehydroepiandrosterone administration in the rhesus monkey. In Vivo 1994 Nov-Dec; 8(6):993-997.

Haffner, S.M.; Valdez, R.A.; Mykkanen, L.; Stern, M.P.; Katz, M.S.: Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in non-diabetic men. Metabolism, 1994 May; 43(5):599-603.

Harland, Simone, Wenzel, Axel F., Dr: Superhormon DHEA. Messidor Verlag (in German)

Henderson, E; Yang JY; Schwartz A.: Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication. AIDS Res Human Retroviruses 1992 May; 8(5):625-31.

Inano H; Ishii-Ohba H; Suzuki K; et al.: Chemoprevention by dietary dehydroepiandrosterone against promotion/progression phase of radiation-induced mammary tumorigenesis in rats. J Steroid Biochem Mol Biol 1995 Jul;54(1-2):47-53.

Iwasaki, M.; Darden, T.A.; Parker, C.E.; Tomer, K.B.; Pedersen, L.G.; Negishi, M.: Inherent versatility of P450 oxygenase. Conferring dehydroepiandrosterone hydroxylase activity to P-450 2a-4 by a single amino acid mutation at position 117. Breast Cancer Rest Treat (3), 1990 Oct, 16;261-272.

Kalimi, Mohammed, Regelson, William: Dehydroepiandrosterone (DHEA), Biochemical, Physiological and Clinical Aspects. de Gruyter, 2001.

Khorram, O., Vu, L., Yen, S.S.: Activation of immune function by Dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci, 52(1):MI-7, 1997, Jan.

Kim, H.R., Ryu, S.Y., et al.: Administration of Dehydroepiandrosterone reverses the immune suppression induced by high dose antigen in mice. Immunol Invest, 24(4):583-93, 1995 May.

Loria,R.M., Padgett, D.A., Huynh, P.N.: Regulation of the immune response by Dehydroepiandrosterone and its metabolites. J Endocrinol, 150 Suppl(): S209-20, 1996 Sept.

Marrero, M.; Prough, R.A.; Frenkel, R.A.; Milewich, L.: Dehydroepiandrosterone feeding and protein phosphorylation, phosphatases and lipogenic enzymes in mouse liver. Exp. Clin. Endocrinol 96(2), 1990 Nov; 149-156.

Mayer, D.; Weber, E.; Bannasch, PI.: Modulation of liver carcinogenesis by dehydroepiandrosterone. In the biological role of dehydroepiandrosterone. Edited by M. Kalimi and W. Regelson, New York: DeGruyter, 1990; 361-385.

Melchior, C.; Ritzmann, R.F.: Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 47(3), 1994 Mar; 437-441.

Merril, C.R.; Hanrington, M.G.; Sunderland, T.; Reduced plasma dehydroepiandrosterone concentrations with HW infections and Alzheimer’s disease. In the biological role of dehydroepiandrosterone. Edited by Kalimi, M. and Regelson, W., New York: de Gruyter, 1990; 101-105.

Miklos, S.: Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis. Acta Biomed Ateneo Parmense, 66(3-4): 139-46, 1995.

Morales, A.J., Nolan, J.J., Nelson, J.C, Yen, S.S.: Effects of replacement dose of Dehydro-epi-androsterone in men and women of advancing age. J Clin Endocrinol Metab, 78(6)L1360-7, 1994, Jan.

Motorola, J.F. and Yen, S.S.C.: The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab, 1990; 71:696-704.

Nestler, J.E.; Clore, J.N.; Blackard, W.G.: Metabolism and actions of dehydroepiandrosterone in humans. J Steroid Biochem Mol Biol, 1991 Dec; 20(4):807-823.

Nestler, J.E.; Clore, J.N.; Blackard, W.G.: Dehydroepiandrosterone: the missing link between hyperinsulinemia and atherosclerosis? FASEB J, 1992 Sept; 6(12):3073-3075.

Nordin, B.E.C., et al.: The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women. J Clin. Endocrinol Metab., 1985; 60:651-657.

Nyce, J.W., et al.: Inhibition of 1,2-dimethylhydrazine induced colon tumeriogenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis, 1984; 5:57-62.

Parough, R.A.; Webb, S.J.; Wu, H.Q.; Lapenson, D.P.; Waxman, D.J.: Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res. 54(11), 1994 Jun 1; 2878-2886.

Ravaglia, G., Forti, P., Maioli, F., et al.: The relationship of Dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over ninety-year-olds. J Clin Endocrinol Metab, 81:3. 1173-8, 1996 Mar.

Regelson, William, M.D., Colman, Carol: The Superhormone Promise, Simon & Schuster.

Regelson, W., Kalimi, M.Y.: Dehydroepiandrosterone (DHEA)- A Pleiotropic Steroid. How can one Steroid do so much? Departments of Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth Richmond, VA.

Regelson, W., Kalimi, M.Y.: Dehydroepiandrosterone (DHEA)- the Multifunctional Steroid. Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

Regelson, W., Loria, R. and M. Kalimi.: Dehydroepiandrosterone (DHEA)- the “Mother Steroid”. Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

Sahelian, Ray, M.D.: DHEA - A Practical Guide – Nature’s Antidote to Aging

Schwartz, A. G., Pashko, L. L.: Cancer Chemoprevention with the Adrenocortial Steroid Dehydroepiandrosterone and Structural Analogs. J. Cell Biochem Suppl. 17G: 73-79. 1993.

Schwarts, A. G., Fairman, D. K., Polansky, M., Lewbart, M. L., Pashko, L. L.: Inhibition of 7,12-Dimethylbenz[a]-anthracene-initiated and 12-0-tetradecanoylphorbol-13-acetate-promoted Skin Papilloma Formation in Mice by Dehydroepiandrosterone and Two Synthetic Analogs. Carcinogenesis (10): 1809. 1989

Schwartz, A.G.; Fairman, D.K., et al.: The biological significance of dehydroepiandrosterone. Carcinogenesis (10), 1988; 1809.

Schwartz, A.G.: Inhibitions of spontaneous breast cancer formation in female C3H(Avy’a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res, 1979; 39:1129-1132.

Siegel, S.F.; Finegold, D.N.; Lanes, R.; Lee, P.A.: ACTH stimulates tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N. Engl. J. Med 323(13), 1990; Sept 27; 909-911, and N. Eng. J. Med 324(8), 1991 Feb 21; 5645 and Metabolism 39(9), 1990 Sept; 967-970.

Simunova, 3.; Gregorova, I.; Soiska, J.: Metabloicke komplekace otylosti-poloss ojejich ovbmmi dehydoeptandrosteron sulfatem. Steroik Ik., 1973; (75) 27-30.

Spivak, C.E.: Desensitization and noncompetitive blockage of GABAA receptors inventral midbrain neurons by a neurosteroid dehydroepiandrosterone sulfate. Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland.Sonka, J.; ACTA Univ. Carol (71), 1971; 1-137, 146-171.

Sonka, J., et al.: Defecit des dehydroepianddrosterone nenee syndrome? Endocrinology, 47, 1965; 152-161. Sonka, J.; Stravkova, M., Aggressologie (5), 1970; 421-426.

Sonka, J., et al.: Serum lipids and dehydroepiandrosterone excretion in normal subjects. Journal of Lipid Research, 9, 1968; 769-772.

Suitters, A.J., Shaw, S., Wales, M.R., et al.: Immune enhancing effects of Dehydroepiandrosterone sulphate and the role of steroid sulphatase. Immunology 91(2):314-21, 1997 Jan.

Sunderland, T.; Nerril, C.R.; Harrington, M.G.: DHEA and Alzheimer’s disease. Lancet (2), 1989; 570.

Taelman, P., et al.: Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause. Matuiitas, 1989; 11:65-73.

Watson, R.R., Huls, et al.: Dehydroepiandrosterone and diseases of aging. Drugs Aging, 1996 Oct, 9:4, 271-91.

Wise, T.; Klindt, J.; Buonomo, F.C.: Obesity and dehydroepiandrosterone / dehydroepiandrosterone sulfate relationships in lean, obese and meat-type cross-bred boars: responses to porcine growth hormone. Endocrinology 1995 Aug; 136(8):3310-7.

Yamaji, T.; Ishibashi, N.; Takau, F., et al., Acta Endocriniol (Copenh) (120), 1989; 655-660. Yang, J.Y.; Schwartz, A.; Henderson, E.E.: Inhibition of 3’azido-3’deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro. Biochem Biophys Res Commun 1994 Jun 30; 201(3):1424-32.

Yang, J.Y.; Schwartz, A.; Henderson, E.E.: Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res Hum Retroviruses 1993 Aug; 9(8): 747-54.

Yen, S.S.; Murphy, A.A.; Kettel, L.M.; Morales, A.J.; Roberts, V.J.: Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 1993 Feb; 76(2): 513-7.

Zumoff, B.; Levin, J.; Rosenfeld, S., et al.: Abnormal 24-hour mean plasma concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate in women with inoperable breast cancer. Cancer Res. (41), 1981; 3360-3363.


Les dossiers suivants sont disponibles pour le téléchargement
2018-05-20
© 2018 EuroHealth®